Characteristics of high risk breast cancer patients with mutations identified by multiplex panel testing

Authors :: Bradley Garman
Benita Weathers
Angela DeMichele
Jessica M. Long
Katherine L. Nathanson
Brandon Wenz
Susan M. Domchek
Noah Goodman
Bradley Wubbenhorst
Christopher Colameco
Jill Stopfer
Kara N. Maxwell
Angela R. Bradbury
Kurt D'Andrea
Jacquelyn Powers
Source :: Journal of Clinical Oncology. 33:1511-1511
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: 1511 Background: Multiplex panel testing studies evaluating cancer susceptibility in breast cancer (BC) patients suggest that between 4-11% of BRCA1/2 negative individuals have a deleterious mutati...

Subjects :: Cancer Research
Breast cancer
Oncology
business.industry
medicine
Cancer susceptibility
Multiplex
skin and connective tissue diseases
medicine.disease
business
Bioinformatics

Full Text Access

Tools